North China Pharmaceutical Co Ltd (600812) — Cash Flow Quality Index
North China Pharmaceutical Co Ltd (600812) has a Cash Flow Quality Index of 4.86x as of September 2025. Operating cash flow of CN¥170.24 Million exceeds net income of CN¥35.01 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of North China Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
North China Pharmaceutical Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for North China Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 600812 cash flow conversion.
Annual Cash Flow Quality Index for North China Pharmaceutical Co Ltd (1998–2025)
Year-by-year earnings quality comparison for North China Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 6.43x | CN¥1.18 Billion | CN¥183.06 Million | ▲ +12.4% |
| 2024 | 5.72x | CN¥1.23 Billion | CN¥214.97 Million | ▼ -97.3% |
| 2023 | 209.45x | CN¥1.02 Billion | CN¥4.89 Million | ▲ +605.6% |
| 2021 | 29.68x | CN¥1.05 Billion | CN¥35.38 Million | ▲ +312.3% |
| 2020 | 7.20x | CN¥752.15 Million | CN¥104.48 Million | ▲ +45.3% |
| 2019 | 4.96x | CN¥732.97 Million | CN¥147.90 Million | ▼ -6.7% |
| 2018 | 5.31x | CN¥774.33 Million | CN¥145.82 Million | ▼ -73.3% |
| 2017 | 19.90x | CN¥287.25 Million | CN¥14.44 Million | ▲ +330.0% |
| 2016 | -8.65x | CN¥-446.53 Million | CN¥51.63 Million | ▼ -459.0% |
| 2015 | 2.41x | CN¥122.50 Million | CN¥50.85 Million | ▼ -15.4% |
| 2014 | 2.85x | CN¥90.56 Million | CN¥31.79 Million | ▲ +120.0% |
| 2013 | -14.22x | CN¥-135.03 Million | CN¥9.49 Million | ▼ -212.9% |
| 2012 | -4.55x | CN¥-63.92 Million | CN¥14.06 Million | ▼ -379.5% |
| 2011 | 1.63x | CN¥227.60 Million | CN¥139.96 Million | ▲ +171.2% |
| 2010 | -2.29x | CN¥-598.35 Million | CN¥261.81 Million | ▼ -157.7% |
| 2008 | 3.96x | CN¥1.09 Billion | CN¥273.95 Million | ▼ -55.8% |
| 2007 | 8.96x | CN¥664.37 Million | CN¥74.11 Million | ▼ -14.2% |
| 2006 | 10.45x | CN¥597.12 Million | CN¥57.12 Million | ▲ +145.2% |
| 2004 | 4.26x | CN¥310.39 Million | CN¥72.81 Million | ▲ +104.1% |
| 2003 | 2.09x | CN¥580.32 Million | CN¥277.87 Million | ▼ -48.4% |
| 2002 | 4.05x | CN¥738.50 Million | CN¥182.52 Million | ▲ +116.9% |
| 2001 | 1.87x | CN¥367.28 Million | CN¥196.84 Million | ▲ +89.0% |
| 2000 | 0.99x | CN¥133.49 Million | CN¥135.24 Million | ▲ +131.8% |
| 1999 | -3.10x | CN¥-373.62 Million | CN¥120.50 Million | ▼ -13.8% |
| 1998 | -2.73x | CN¥-326.74 Million | CN¥119.90 Million | — |